INTRODUCTION
Necrotizing soft tissue infections are rapidly progressing infections with necrosis of the skin, subcutaneous tissue, vessels and superficial fascia (fascia superficialis). 1, 2 If untreated the condition can progress to SIRS, MODS & death. Necrotizing fasciitis infection was first described by Jones in 1871 and termed as "hospital gangrene". 3 First surgical debridement was performed in 1920 by Meleney and still plays the key role in the treatment of such infective conditions. 4, 5 Necrotizing soft tissue infections are broadly categorized into:
 Type 1-Polymicrobial/synergestic,  Type 2-Monomicrobial (includes Group A Beta haemolytic Streptococcus ),  Type 3-Marine related organisms including Vibrio vulnificus,  Type 4 -Fungal. 6, 7 The laboratory risk indicator for necrotising fasciitis (LRINEC) was first described by Wong et al. 8 The tool consists of six parameters at the time of presentation: Creactive protein (CRP), total white cell count, haemoglobin, serum sodium, serum creatinine and blood glucose (Table 1) . Table 1 describes the parameters used in LRINEC scoring system and their scores. Based on the scores patients were categorized into low risk (<5); intermediate risk (6) (7) ; high risk (>8). The objective of this study is to evaluate the efficacy of LRINEC score in clinical evaluation in the management and prognosis of patients with soft tissue necrotizing infections.
METHODS

This prospective study was carried out in Sri Padmavathi
Medical College (W), SVIMS, Tirupati over a period of 9 months from May 2018 to January 2019.
A total number of 50 patients were included in the study.
Inclusion criteria
All patients with severe soft tissue infection of lower limbs who required hospital admission for surgical procedure were taken into the study.
Exclusion criteria
Children below the age of 13 years, pregnant women, associated malignancies.
Patients with severe soft tissue infection of lower limbs were evaluated at the time of admission and blood investigations in the LRINEC score were obtained and score was calculated. Patients were treated with i.v. fluids, i.v. antibiotics, surgical debridement and fasciotomy.
RESULTS
50 patients of Indian origin were taken into the study with age group ranging from 40-60 years.
Male to female ratio was 4:1. Risk factors predisposing to necrotizing soft tissue infections included diabetes mellitus 39 (78%), trauma 32 (64%), jaundice 12 (24%), smoking 24 (48%), alcoholism 30 (60%), renal disease 11 (22%), peripheral vascular disease 18 (36%) multi organ failure 9 (18%).
Symptoms included painful swelling of affected lower limb 42 (84%), fever 34 (68%), bullae 29 (58%), decreased urine output 23 (46%).
Describes the categorization of patients based on LRINEC score and the associated mortality rate ( Table  2) . 16 patients were categorized into Low risk group with 0% mortality, 27 patients were categorized into Moderate risk with 0% mortality and 7 patients were categorized into high risk with a mortality of 57%. Describes the various surgical procedures performed on these patients (Table 3) . Procedures ranging from single surgical debridement (36%), multiple surgical debridement (66%) and split thickness skin grafting (10%), below knee amputation (6%), above knee amputation (4%) were performed.
Describes the demographic data of the patients consisting of the nationality with comorbid conditions & the outcomes (Table 4 ).
This study proves that LRINEC score is an economical and a good diagnostic modality to predict the outcomes & prognosis of patients with necrotizing soft tissue infections.
DISCUSSION
Wong et al identified a LRINEC score of ≥6 with a suspicion of necrotizing fasciitis and a score of ≥8 having a strong prediction for necrotizing fasciitis. 8 It is evident that the LRINEC score is a reliable scoring method to detect and differentiate early cases of necrotizing fasciitis among patients with severe soft tissue infections. It is necessary to have a systematic approach for the early identification of the disease, early surgical intervention and to decrease the morbidity and mortality among patients with necrotizing soft tissue infections.
Necrotizing fasciitis leads to severe sepsis and associated systemic inflammatory response syndrome leading to changes in the biochemical and hematologic values. The LRINEC score measures these changes and interprets the probability of necrotizing fasciitis and the severity of sepsis.
Frozen section biopsy and MRI scans of the affected part have been used in the early diagnosis of necrotizing fasciitis. It is not possible to subject all patients with the suspicion of necrotizing fasciitis to frozen section biopsies and MRI scanning as the procedures is associated with morbidity and costly. The "finger test" should be considered as an alternative. Under local anesthesia a 2 cms incision is made up to the deep fascia and a gentle probing with the index finger is performed at the level of the deep fascia. The lack of bleeding, presence of characteristic "dishwater pus," and lack of tissue resistance to blunt finger dissection are features of a positive finger test and suggests necrotizing fasciitis. 10 The diagnosis of necrotizing soft tissue infections needs high clinical index of suspicion & needs immediate surgical debridement. 7 The LRINEC uses simple laboratory investigations at the time of admissions for patients with necrotizing fasciitis and stratifies the patients into low, intermediate and high risk groups subjecting them for surgical procedures. Serial LRINEC scores can be obtained to check for the presence of infections and escalation of antibiotic treatment or repeated surgical debridements. Care should be taken to treat other comorbidities. Presence of neutropenia indicates neutropenic sepsis and is a poor prognostic indicator.
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CONCLUSION
The LRINEC score is a good tool to classify the degree of sepsis in necrotizing fasciitis at the emergency department categorizing the patients for surgical management. In developing countries like India, this is an economical investigative modality and can be repeated to assess the success of initial surgical debridement.
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